0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Other Articles |

SYMPTOMATIC THERAPY IN MALIGNANT DIPHTHERIA

DANIEL C. DARROW, M.D.; HERMAN YANNET, M.D.
Am J Dis Child. 1935;49(1):60-68. doi:10.1001/archpedi.1935.01970010069006.
Text Size: A A A
Published online

In the past ten years malignant diphtheria has increased alarmingly in Europe and has occasionally assumed epidemic proportions, with a mortality rate of from 30 to 60 per cent, in spite of the administration of large doses of antitoxin. Attempts to explain the high death rate by identifying a new strain of the diphtheria bacillus have been unsuccessful. Furthermore, accompanying infections with other organisms do not seem to play a deciding rôle in the development of malignant diphtheria.1 The suggestion that the high rate of mortality was due, in great part, to the physiologic disturbances produced by the diphtheria toxin before the neutralizing effect of antitoxin was obtained, and that therapeutic success required the adequate symptomatic treatment of these disturbances was responsible for the studies reported in the earlier papers of this series.2 In the present article the treatment of malignant diphtheria from the physiologic point of view

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();